ATE271377T1 - Arzneimittelform mit zwei überzugs-schichten - Google Patents

Arzneimittelform mit zwei überzugs-schichten

Info

Publication number
ATE271377T1
ATE271377T1 AT98944477T AT98944477T ATE271377T1 AT E271377 T1 ATE271377 T1 AT E271377T1 AT 98944477 T AT98944477 T AT 98944477T AT 98944477 T AT98944477 T AT 98944477T AT E271377 T1 ATE271377 T1 AT E271377T1
Authority
AT
Austria
Prior art keywords
coating layers
medicinal form
coating layer
substance
medicinal
Prior art date
Application number
AT98944477T
Other languages
English (en)
Inventor
Gerald A Walter
Robert W Shen
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Application granted granted Critical
Publication of ATE271377T1 publication Critical patent/ATE271377T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5015—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT98944477T 1997-08-29 1998-08-25 Arzneimittelform mit zwei überzugs-schichten ATE271377T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5721697P 1997-08-29 1997-08-29
PCT/US1998/017328 WO1999011245A1 (en) 1997-08-29 1998-08-25 A pharmaceutical composition having two coating layers

Publications (1)

Publication Number Publication Date
ATE271377T1 true ATE271377T1 (de) 2004-08-15

Family

ID=22009215

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98944477T ATE271377T1 (de) 1997-08-29 1998-08-25 Arzneimittelform mit zwei überzugs-schichten

Country Status (15)

Country Link
US (2) US6228397B1 (de)
EP (1) EP1007009B1 (de)
JP (1) JP2001514210A (de)
KR (1) KR100540715B1 (de)
CN (1) CN1150893C (de)
AT (1) ATE271377T1 (de)
AU (1) AU743154B2 (de)
CA (1) CA2299511C (de)
DE (1) DE69825165T2 (de)
DK (1) DK1007009T3 (de)
ES (1) ES2226168T3 (de)
NZ (1) NZ503086A (de)
PT (1) PT1007009E (de)
SI (1) SI1007009T1 (de)
WO (1) WO1999011245A1 (de)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6057139A (en) 1995-06-29 2000-05-02 Mcneil-Ppc, Inc. Preblend of microcrystalline cellulose and lactase for making tablets
US8563522B2 (en) 1997-07-08 2013-10-22 The Iams Company Method of maintaining and/or attenuating a decline in quality of life
NZ503086A (en) * 1997-08-29 2002-03-01 Upjohn Co An orally administrable pharmaceutical composition comprising an inner core and two outer layers, which render it substantially free of unpleasant tastes
WO2000076478A1 (en) 1999-06-14 2000-12-21 Cosmo S.P.A. Controlled release and taste masking oral pharmaceutical compositions
US8895064B2 (en) 1999-06-14 2014-11-25 Cosmo Technologies Limited Controlled release and taste masking oral pharmaceutical composition
JP3718398B2 (ja) * 2000-01-11 2005-11-24 信越化学工業株式会社 フィルムコーティング剤及び経口固形製剤
US6645180B1 (en) 2000-09-15 2003-11-11 Thomas Hatch Single-use syringe
AU4061702A (en) * 2001-05-15 2003-04-03 Mcneil-Ppc, Inc. Dip coating compositions containing starch or dextrin
US20030070584A1 (en) * 2001-05-15 2003-04-17 Cynthia Gulian Dip coating compositions containing cellulose ethers
US8309118B2 (en) * 2001-09-28 2012-11-13 Mcneil-Ppc, Inc. Film forming compositions containing sucralose
US7429619B2 (en) 2002-08-02 2008-09-30 Mcneil Consumer Healthcare Polyacrylic film forming compositions
US8168170B2 (en) 2002-10-03 2012-05-01 The Procter And Gamble Company Compositions having an inner core and at least three surrounding layers
US8894991B2 (en) 2003-12-19 2014-11-25 The Iams Company Canine probiotic Lactobacilli
US7785635B1 (en) 2003-12-19 2010-08-31 The Procter & Gamble Company Methods of use of probiotic lactobacilli for companion animals
US20050152884A1 (en) 2003-12-19 2005-07-14 The Procter & Gamble Company Canine probiotic Bifidobacteria globosum
US8877178B2 (en) 2003-12-19 2014-11-04 The Iams Company Methods of use of probiotic bifidobacteria for companion animals
US20050158294A1 (en) 2003-12-19 2005-07-21 The Procter & Gamble Company Canine probiotic Bifidobacteria pseudolongum
GB0330009D0 (en) * 2003-12-24 2004-01-28 Ferrosan As Probiotic tablet formulations
JP2008534591A (ja) * 2005-03-29 2008-08-28 マクニール−ピーピーシー・インコーポレーテツド 疎水性溶媒内に親水性薬剤を有する組成物
ATE512211T1 (de) 2005-05-31 2011-06-15 Iams Company Feline probiotische lactobacilli
ES2607988T3 (es) 2005-05-31 2017-04-05 Iams Europe B.V. Bifidobacterias probióticas felinas
US20070098746A1 (en) * 2005-11-02 2007-05-03 Nichols William M Multi-layered coating technology for taste masking
US20070184111A1 (en) * 2006-02-03 2007-08-09 Pharmavite Llc Hybrid tablet
US20080131467A1 (en) * 2006-11-30 2008-06-05 Dennis Nelson Film-coated solid dosage form
ES2551719T3 (es) 2007-02-01 2015-11-23 Iams Europe B.V. Procedimiento para disminuir la inflamación y el estrés en un mamífero usando antimetabolitos de glucosa, aguacate o extractos de aguacate
US8404275B2 (en) * 2007-07-01 2013-03-26 Vitalis Llc Combination tablet with chewable outer layer
US8486452B2 (en) * 2007-07-20 2013-07-16 Mylan Pharmaceuticals Inc. Stabilized tolterodine tartrate formulations
US8110226B2 (en) * 2007-07-20 2012-02-07 Mylan Pharmaceuticals Inc. Drug formulations having inert sealed cores
US9771199B2 (en) 2008-07-07 2017-09-26 Mars, Incorporated Probiotic supplement, process for making, and packaging
US10104903B2 (en) 2009-07-31 2018-10-23 Mars, Incorporated Animal food and its appearance
US10154964B2 (en) 2011-09-07 2018-12-18 Cosmo Technologies Limited Controlled release and taste masking oral pharmaceutical composition
EP2770978B1 (de) 2011-10-28 2018-01-10 Vitalis LLC Zusammensetzungen mit reduzierter ausschwemmung
CN104274408A (zh) * 2013-07-10 2015-01-14 北京科信必成医药科技发展有限公司 一种熔融包衣的速释药物微粒及其制备方法
CN107361392B (zh) * 2017-07-26 2019-10-25 云南芯韵科技开发有限公司 一种三层含水胶囊及其制备方法
BR112023013880A2 (pt) 2021-01-11 2023-10-17 Bpsi Holdings Llc Revestimentos de alta opacidade e substratos revestidos com os mesmos
US12303604B1 (en) 2024-10-16 2025-05-20 Currax Pharmaceuticals Llc Pharmaceutical formulations comprising naltrexone and/or bupropion

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4828857A (en) * 1984-10-05 1989-05-09 Warner-Lambert Company Novel sweetener delivery systems
US4804548A (en) * 1984-10-05 1989-02-14 Warner-Lambert Company Novel sweetener delivery systems
US4849227A (en) * 1986-03-21 1989-07-18 Eurasiam Laboratories, Inc. Pharmaceutical compositions
US4842867A (en) * 1986-05-09 1989-06-27 Alza Corporation Pulsed drug delivery of doxylamine
NL8601890A (nl) * 1986-07-21 1988-02-16 Polynorm Nv Werkwijze voor het vervaardigen van een paneel.
JPH0636720B2 (ja) 1986-11-06 1994-05-18 不二製油株式会社 大豆蛋白の製造法
US4808413A (en) * 1987-04-28 1989-02-28 E. R. Squibb & Sons, Inc. Pharmaceutical compositions in the form of beadlets and method
US5082669A (en) 1989-07-20 1992-01-21 Dainippon Pharmaceutical Co., Ltd. Rapid-releasing oral particle pharmaceutical preparation with unpleasant taste masked
CA2063141C (en) * 1989-08-04 1997-03-04 Edward J. Roche Rotogranulations and taste masking coatings for preparation of chewable pharmaceutical tablets
NZ234587A (en) * 1989-08-04 1991-11-26 Mcneil Ppc Inc A chewable pharmaceutical tablet of compressed coated granules
EP0502119B1 (de) * 1989-11-13 1996-01-31 Scios Nova, Inc. Liposphären zur kontrollierten substanzabgabe
IE61651B1 (en) * 1990-07-04 1994-11-16 Zambon Spa Programmed release oral solid pharmaceutical dosage form
US5380535A (en) * 1991-05-28 1995-01-10 Geyer; Robert P. Chewable drug-delivery compositions and methods for preparing the same
CA2068402C (en) * 1991-06-14 1998-09-22 Michael R. Hoy Taste mask coatings for preparation of chewable pharmaceutical tablets
US5490987A (en) * 1991-07-03 1996-02-13 The Upjohn Company Tableting of colestipol hydrochloride
US5429825A (en) * 1992-06-26 1995-07-04 Mcneil-Ppc, Inc. Rotomelt granulation
MX9306393A (es) * 1992-10-16 1994-04-29 Glaxo Group Ltd Composiciones de ranitidina substancialmente libres de sabor amargo, proceso para su preparacion y composiciones farmaceuticas que las contienen.
NZ503086A (en) * 1997-08-29 2002-03-01 Upjohn Co An orally administrable pharmaceutical composition comprising an inner core and two outer layers, which render it substantially free of unpleasant tastes
US5891476A (en) * 1997-12-22 1999-04-06 Reo; Joe P. Tastemasked pharmaceutical system

Also Published As

Publication number Publication date
DE69825165D1 (de) 2004-08-26
CN1150893C (zh) 2004-05-26
US6939560B2 (en) 2005-09-06
SI1007009T1 (en) 2004-12-31
PT1007009E (pt) 2004-10-29
US20010000471A1 (en) 2001-04-26
CN1265029A (zh) 2000-08-30
EP1007009B1 (de) 2004-07-21
JP2001514210A (ja) 2001-09-11
CA2299511A1 (en) 1999-03-11
AU743154B2 (en) 2002-01-17
KR100540715B1 (ko) 2006-01-10
AU9201198A (en) 1999-03-22
DK1007009T3 (da) 2004-11-01
KR20010023384A (ko) 2001-03-26
EP1007009A1 (de) 2000-06-14
DE69825165T2 (de) 2005-07-14
ES2226168T3 (es) 2005-03-16
WO1999011245A1 (en) 1999-03-11
HK1028880A1 (en) 2001-03-09
CA2299511C (en) 2007-01-02
NZ503086A (en) 2002-03-01
US6228397B1 (en) 2001-05-08

Similar Documents

Publication Publication Date Title
ATE271377T1 (de) Arzneimittelform mit zwei überzugs-schichten
NO890075D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive imidazoler.
EA199700230A1 (ru) Дозирующий ингалятор для дипропионата беклометазона
BR1100860A (pt) Composto, droga antiinflamatória, composição farmacêutica, epìmero r e epìmero s do composto
ATE450259T1 (de) Orale dosierungsform enthaltend einen therapeutischen wirkstoff und einen gegenwirdenden wirkstoff
DZ2494A1 (fr) Composition pharmaceutique d'oméprazole.
HUP9800410A2 (hu) Szájon át adható 2-metil-tieno-benzodiazepin-készítmény
DE69842173D1 (de) Neue Suppositoriumsform mit säureempfindlichem Wirkstoff
WO1997015269A3 (en) Method, compositions and kits for increasing the oral bioavailability of pharmaceutical agents
CA2235520A1 (fr) Comprimes bioadhesifs
ATE476957T1 (de) Pharmazeutische zusammensetzung auf fondantbasis
CA2182004A1 (en) Film Coated Tablet of Paracetamol and Domperidone
KR920002151A (ko) 15-케토-프로스타글란딘 화합물에 의한 염증성 질환 치료
CA2433833A1 (en) Use of flumazenil in developing a drug for the treatment of alcohol dependence
JP2001513504A5 (de)
ES2177024T3 (es) Empleo de la fanquinoma para el tratamiento de la enfermedaad de alzheimer.
KR910007531A (ko) 15-케토-프로스타글란딘 화합물을 이용한 간 담즙성 질병의 치료
MX9306564A (es) Forma de medicamento oral.
KR920019365A (ko) 디리트로마이신을 함유하는 약학 제형
EP0781558A3 (de) Pharmazeutische Verwendung von Heparin Kofaktor II
HUP9802716A2 (hu) Fájdalomcsillapító gyógyszerkombináció
DK165966C (da) Forbedret piroxicamholdigt anti-inflammatorisk praeparat
FR2705895B1 (fr) Comprimés médicamenteux exempts d'agent lubrifiant.
BE2016C017I2 (de)
EP0185586A3 (de) Arzneimittel auf Basis von Zink-Gluconat, verwendbar bei der Behandlung von Hyperprolactinämie

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1007009

Country of ref document: EP

EEFA Change of the company name
REN Ceased due to non-payment of the annual fee